Cellectar Biosciences Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,473.40
9,477.60
3,912.80
11,499.60
10,061.40
13,310.60
Other Current Assets
294.70
220.60
267.80
693.60
878.00
641.20
Total Current Assets
2,768.10
9,698.20
4,180.60
12,193.20
10,939.40
13,951.80
Net Property, Plant & Equipment
2,360.50
2,033.90
1,728.50
1,444.10
244.70
543.30
Intangible Assets
1,675.50
1,675.50
1,675.50
1,675.50
1,675.50
-
Other Assets
11.90
11.90
11.90
11.90
11.90
558.90
Total Assets
6,815.90
13,419.50
7,596.40
15,324.60
12,871.50
15,054.10
ST Debt & Current Portion LT Debt
1.70
122.10
246.00
89.30
3.00
Accounts Payable
1,162.10
-
-
1,416.40
1,867.80
Income Tax Payable
3,359.40
1,128.50
-
-
-
Other Current Liabilities
0.00
934.00
5,457.00
127.10
244.00
Total Current Liabilities
4,523.20
2,184.60
5,703.00
1,632.90
2,114.80
Long-Term Debt
450.00
341.20
94.60
5.20
2.20
Other Liabilities
143.20
147.80
148.90
146.60
-
Total Liabilities
5,116.40
2,673.60
5,946.60
1,784.70
2,117.00
Common Equity (Total)
1,699.60
10,745.90
1,649.80
12,674.70
9,758.70
Total Shareholders' Equity
1,699.60
10,745.90
1,649.80
13,539.90
10,754.50
Total Equity
1,699.60
10,745.90
1,649.80
13,539.90
10,754.50
Liabilities & Shareholders' Equity
6,815.90
13,419.50
7,596.40
15,324.60
12,871.50
Preferred Stock (Carrying Value)
-
-
-
865.10
995.80
About Cellectar Biosciences
View Profile
